MAKO SURGICAL CORP. (MAKO) financial statements (2021 and earlier)

Company profile

Business Address 2555 DAVIE ROAD
FT. LAUDERDALE, FL 33317
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments536070 
Cash and cash equivalents132041 
Short-term investments404028 
Receivables162115 
Inventory, net of allowances, customer advances and progress billings252225
Inventory252225 
Deferred costs111 
Derivative instruments and hedges, assets  7 
Prepaid expense and other current assets2 
Other undisclosed current assets33  
Total current assets:98106120 
Noncurrent Assets
Property, plant and equipment222223 
Long-term investments and receivables331 
Long-term investments331 
Intangible assets, net (including goodwill)565
Intangible assets, net (excluding goodwill)565 
Other noncurrent assets33 
Prepaid expense and other noncurrent assets3 
Other undisclosed noncurrent assets444 
Total noncurrent assets:383837 
TOTAL ASSETS:137145157 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities211412 
Accounts payable122 
Accrued liabilities1578 
Employee-related liabilities553 
Deferred revenue and credits10109 
Other undisclosed current liabilities8   
Total current liabilities:392420 
Noncurrent Liabilities
Liabilities, other than long-term debt111 
Deferred revenue and credits111 
Total noncurrent liabilities:111 
Total liabilities:402421 
Stockholders' equity
Stockholders' equity attributable to parent97120136 
Common stock000 
Additional paid in capital369371367 
Accumulated other comprehensive loss(0)(0)(0) 
Accumulated deficit(272)(251)(231) 
Total stockholders' equity:97120136 
TOTAL LIABILITIES AND EQUITY:137145157 

Income statement (P&L) ($ in millions)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Revenues232825 
Revenue, net202018 
Cost of revenue(6)(11)(7) 
Cost of goods and services sold(5)(8)(4) 
Gross profit:161718 
Operating expenses(38)(30)(27) 
Operating loss:(21)(13)(9) 
Nonoperating expense(0)(7)(1) 
Loss from continuing operations before income taxes:(21)(20)(10) 
Income tax expense  (0) 
Net loss available to common stockholders, diluted:(21)(20)(10) 

Comprehensive Income ($ in millions)

9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
12/31/2012
Q4
Net loss:(21)(20)(10) 
Comprehensive loss:(21)(20)(10) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0) 
Comprehensive loss, net of tax, attributable to parent:(21)(20)(10) 

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: